Oluwaseun Olusegun Fatoba, PhD

Affiliations: 
2004-2009 Human Anatomy Ladoke Akintola University, Nigeria 
 2011-2012 Human Anatomy University of Lagos, Nigeria 
 2013-2017 Neuroimmunology Ruhr-University Bochum/International Graduate School of Neuroscience 
 2018-2018 Neuroimmunology Ruhr-University Bochum, Bochum, Nordrhein-Westfalen, Germany 
 2019- Molecular Neuroscience Osaka University/Immunology Frontier Research Center 
Area:
Neurodegenerative diseases
Google:
"Oluwaseun Fatoba"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Ralf Gold grad student 2013-2018 Ruhr University–Bochum, Germany
 (Gisa Ellrichmann as co-mentor)
Toshihide Yamashita post-doc 2019- Osaka University

Collaborators

Sign in to add collaborator
Gal Bitan collaborator
Simon Ebbinghaus collaborator
kalliopi Pitarokoili collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ellrichmann G, Blusch A, Fatoba O, et al. (2019) Author Correction: Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 9: 4960
Fatoba O, Kloster E, Reick C, et al. (2018) Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease. Experimental Neurology
Ellrichmann G, Blusch A, Fatoba O, et al. (2017) Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 7: 4947
Pitarokoili K, Kohle F, Motte J, et al. (2017) Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis. Journal of Neuroimmunology. 309: 58-67
Vöpel T, Bravo-Rodriguez K, Mittal S, et al. (2017) Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01. Journal of the American Chemical Society
Fatoba O, Kloster E, Saft C, et al. (2016) L22 Intranasal application of NPY and NPY13–36 ameliorate disease pathology in R6/2 mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87
Ellrichmann G, Blusch A, Fatoba O, et al. (2016) L7 Laquinimod in the R6/2 mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87
Fatoba O, Ellrichmann G, Saft C, et al. (2016) Activation of neuropeptide-Y2 receptor mediates neuroprotection in cellular model of Huntington's disease Neuropeptides. 55: 5
See more...